JP5491631B2 - 肛門性器路の癌の早期診断方法 - Google Patents

肛門性器路の癌の早期診断方法 Download PDF

Info

Publication number
JP5491631B2
JP5491631B2 JP2012529163A JP2012529163A JP5491631B2 JP 5491631 B2 JP5491631 B2 JP 5491631B2 JP 2012529163 A JP2012529163 A JP 2012529163A JP 2012529163 A JP2012529163 A JP 2012529163A JP 5491631 B2 JP5491631 B2 JP 5491631B2
Authority
JP
Japan
Prior art keywords
methylation
cancer
znf671
astn1
hpv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012529163A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505007A (ja
JP2013505007A5 (https=
Inventor
ドゥルスト，マティアス
ハンセル，アルフレッド
ステインバッハ，ダニエル
Original Assignee
オンクグノスティクス ゲーエムベーハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オンクグノスティクス ゲーエムベーハー filed Critical オンクグノスティクス ゲーエムベーハー
Publication of JP2013505007A publication Critical patent/JP2013505007A/ja
Publication of JP2013505007A5 publication Critical patent/JP2013505007A5/ja
Application granted granted Critical
Publication of JP5491631B2 publication Critical patent/JP5491631B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2012529163A 2009-09-18 2010-09-17 肛門性器路の癌の早期診断方法 Active JP5491631B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09011941A EP2308998A1 (de) 2009-09-18 2009-09-18 Verfahren zur frühen Diagnose von Karzinomen des Anogenitaltraktes
EP09011941.3 2009-09-18
PCT/EP2010/005735 WO2011032721A1 (de) 2009-09-18 2010-09-17 Verfahren zur frühen diagnose von karzinomen des anogenitaltraktes

Publications (3)

Publication Number Publication Date
JP2013505007A JP2013505007A (ja) 2013-02-14
JP2013505007A5 JP2013505007A5 (https=) 2013-10-03
JP5491631B2 true JP5491631B2 (ja) 2014-05-14

Family

ID=41564137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012529163A Active JP5491631B2 (ja) 2009-09-18 2010-09-17 肛門性器路の癌の早期診断方法

Country Status (7)

Country Link
US (2) US8575326B2 (https=)
EP (2) EP2308998A1 (https=)
JP (1) JP5491631B2 (https=)
CA (1) CA2774458C (https=)
DK (1) DK2478117T3 (https=)
ES (1) ES2431301T3 (https=)
WO (1) WO2011032721A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102082098B1 (ko) * 2012-05-11 2020-02-26 국립연구개발법인 고쿠리츠간켄큐센터 신장 세포암의 예후 예측방법
CN104513851B (zh) * 2013-10-08 2017-01-11 陈永恩 侦测膀胱癌的新颖表基因生物标记及其方法
DE102015101555A1 (de) * 2015-02-03 2016-08-04 Oncgnostics GmbH BioInstrumentezentrum Jena Verfahren und Kit zur Bestimmung des Risikos einer Entwicklung eines Zervixkarzinoms oder einer seiner malignen Vorstufen
EP3688194A1 (en) * 2017-09-29 2020-08-05 Oncgnostics GmbH Risk determination for neoplasia and cancer
CN107760788B (zh) * 2017-12-05 2021-03-02 武汉艾米森生命科技有限公司 一种检测宫颈细胞基因甲基化的核酸组合及试剂盒与应用
US12584177B2 (en) * 2019-01-24 2026-03-24 Mayo Foundation For Medical Education And Research Detecting endometrial cancer
CN110452984A (zh) * 2019-07-29 2019-11-15 韩林志 一种用于宫颈癌甲基化检测的甲基化基因组合、引物和探针组合、试剂盒及其使用方法
CA3154354A1 (en) 2019-10-31 2021-05-06 William R. Taylor Detecting ovarian cancer
CA3162799A1 (en) * 2019-12-23 2021-07-01 Benjamin F. DELATTE Methods and kits for the enrichment and detection of dna and rna modifications and functional motifs
JP2024511561A (ja) 2021-02-26 2024-03-14 オンクグノスティクス ゲーエムベーハー 頭頸部癌の診断およびリスク判定
CN112941189B (zh) * 2021-05-06 2023-07-21 中南大学 宫颈癌早筛分子标志物znf671基因甲基化检测的引物探针组合物及试剂盒和使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019058A1 (de) * 2000-04-06 2001-12-20 Epigenomics Ag Detektion von Variationen des DNA-Methylierungsprofils
US20070105105A1 (en) * 2003-05-23 2007-05-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
EP1639090A4 (en) * 2003-06-09 2008-04-16 Univ Michigan COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER

Also Published As

Publication number Publication date
EP2478117A1 (de) 2012-07-25
CA2774458C (en) 2021-04-27
JP2013505007A (ja) 2013-02-14
DK2478117T3 (da) 2013-10-28
US8575326B2 (en) 2013-11-05
WO2011032721A1 (de) 2011-03-24
US20130344479A1 (en) 2013-12-26
EP2478117B1 (de) 2013-07-31
ES2431301T3 (es) 2013-11-25
EP2308998A1 (de) 2011-04-13
US9228238B2 (en) 2016-01-05
CA2774458A1 (en) 2011-03-24
US20120208180A1 (en) 2012-08-16

Similar Documents

Publication Publication Date Title
JP5491631B2 (ja) 肛門性器路の癌の早期診断方法
JP6369857B2 (ja) 肝細胞癌に関する情報の取得方法、ならびに肝細胞癌に関する情報を取得するためのマーカーおよびキット
US20150361502A1 (en) Method for screening cancer
JP6381020B2 (ja) 大腸癌に関する情報の取得方法、ならびに大腸癌に関する情報を取得するためのマーカーおよびキット
WO2010118559A1 (zh) 一种癌症筛检的方法
JP5209272B2 (ja) 肝臓癌関連遺伝子、及び肝臓癌リスクの判定方法
CN107475443A (zh) 子宫颈癌检测套组
CN117265096A (zh) 用于宫颈高级别病变和宫颈癌早期检测的试剂盒
CN116144782A (zh) 一种用于肺癌检测的组合标志物及其应用
CN108949923B (zh) 一种扩增msf1基因的方法及试剂盒与应用
EP3162899A1 (en) Biomarker for breast cancer
KR102492149B1 (ko) 난소암 진단 또는 감별진단을 위한 마이크로rna-1246 및 이의 용도
JP5602355B2 (ja) 癌患者の外科的手術後の治療選択方法及び予後診断
CN116356027B (zh) 一种用于食管鳞癌或癌前病变检测的试剂、试剂盒及应用
CN116024342B (zh) 用于检测宫颈癌或癌前病变的核酸产品、试剂盒及应用
KR20220052462A (ko) 난소암 진단 또는 감별진단을 위한 마이크로rna-1290 및 이의 용도
CN116162707B (zh) 检测cyth2基因或/和six3基因中的目标区域的甲基化水平的试剂的新应用
CN114196755B (zh) 用于诊断受试者宫颈病变的组合物及用途
CN121759599A (zh) 肿瘤相关的dna甲基化生物标志物组合、检测方法和试剂盒
CN118792405A (zh) 一种诊断宫颈癌的甲基化标志物组合及其应用
CN120464734A (zh) 用于检测卵巢癌的组合物及其用途
AU2023408532A1 (en) Methylation marker for cancer
WO2024204603A1 (ja) 膀胱癌のバイオマーカー
CN120330333A (zh) 用于体外检测子宫内膜癌的甲基化标志物ocel1基因、olig2基因及其用途
CN118581218A (zh) 用于hpv阴性宫颈癌检测的核酸产品、试剂盒及应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130819

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130819

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20130819

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20131002

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131015

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140106

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140204

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140227

R150 Certificate of patent or registration of utility model

Ref document number: 5491631

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250